News

Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae. The $7.22-per-share deal for 89.8% of Sage is a 30 ...
Discover real-time Stryker Corporation Common Stock (SYK) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
The latest news and headlines from Yahoo News. Get breaking news stories and in-depth coverage with videos and photos.